Wegovy, Zepbound, Saxenda, and Foundayo are all approved as weight loss medications for the following people with a demonstrated medical need to lose weight
FLOW Trial Committees and Investigators
When appetite drops, protein, fibre and micronutrients drop with it
The goal is to eliminate the need for lifelong injections and reduce side effects caused by hormone spikes
Weight loss after obesity is associated with increased food motivation and faster weight regain in mice
When clinical studies demonstrated that GLP1 drugs (e.g., semaglutide, tirzepatide), developed to treat diabetes, are effective weight loss drugs that directly act on the brains satiety center to reduce food intake (also drink less alcohol and smoke fewer cigarettes) doctors began prescribing them to help reduce the health risks associated with obesity